Trademark: 90716777
Word
SUVALENT
Status Date
Monday, May 27, 2024
Filing Date
Monday, May 17, 2021
Published for Opposition
Tuesday, March 1, 2022
Abandoned Date
Monday, May 27, 2024
5 Pharmaceuticals and medicines for the prevention and treatment of cancer; pharmaceuticals and medicines for the identification and treatment of tumors; pharmaceuticals preparations in the form of capsules, tablets, and powders for the treatment of cancer; intravenous pharmaceuticals, namely, vials for intravenous administration sold filled with preparations for the treatment of cancer; biological preparations for the prevention and treatment of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in the for testing and treatment of cancer; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations in the nature of drug delivery agents that facilitate administration of other pharmaceutical preparations into the human body for enhanced treatment of cancer
42 Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; testing, inspection, research, or development of pharmaceutical preparations for the prevention and treatment of cancer; research and development of pharmaceuticals and medicines for the identification and treatment of tumors; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the fields of pharmaceutical and biological preparations; development of new technology for others in the fields of pharmaceuticals, biotechnology, and medicine; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; biological research and analysis; chemical research; medical research, namely, conducting clinical trials for others
May 20, 2021
New Application Entered
Aug 16, 2021
New Application Office Supplied Data Entered
Jan 25, 2022
Assigned To Examiner
Mar 1, 2022
Published For Opposition
Mar 1, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 26, 2022
Approved For Pub - Principal Register
Feb 9, 2022
Notification Of Notice Of Publication E-Mailed
Oct 6, 2022
Sou Extension 1 Filed
Apr 26, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 6, 2022
Sou Teas Extension Received
Oct 6, 2022
Sou Extension 1 Granted
Apr 14, 2023
Sou Teas Extension Received
Apr 14, 2023
Sou Extension 2 Filed
Apr 14, 2023
Sou Extension 2 Granted
Oct 24, 2023
Sou Teas Extension Received
Oct 27, 2023
Notice Of Approval Of Extension Request E-Mailed
May 27, 2024
Abandonment - No Use Statement Filed
Jul 12, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 24, 2023
Sou Extension 3 Granted
Oct 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 24, 2023
Sou Extension 3 Filed
Trademark Alertz updated from USPTO on 2030-01-24
